A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta

A blood sample from the mother will be taken within 24 hours before/after the delivery.

Blood samples from the infant will be taken within 24 hours after birth, at Week 4 and at Week 8.

A blood sample from the umbilical cord will be taken directly (within 1 hour ) after delivery.

"Mothers who decided to continue on, or to start treatment with, CZP for an approved indication with their treating physician prior to participation into this study. The mother is responsible for procuring her own supply of commercial CZP. The CZP dose and administration schedule will be as per the locally approved label.~* Active Substance: Certolizumab Pegol~* Pharmaceutical Form: Solution for injection~* Concentration: 200 mg/ml~* Route of Administration: Subcutaneous Use"